Skip to main content
. 2022 Sep 14;181(11):3889–3898. doi: 10.1007/s00431-022-04614-5

Fig. 2.

Fig. 2

Outcomes of cytomegalovirus-positive patients according to the presence of refractory or probable refractory cytomegalovirus infection